Eating more whole plant foods like vegetables, legumes, nuts, and whole grains may help reduce death risk in people with type 2 diabetes, but the evidence is not strong enough to be certain, possibly because other factors like overall diet quality or lifestyle play a role.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review and meta-analysis would determine whether the association between healthy plant-based diet adherence and reduced mortality in type 2 diabetes is consistent across studies, despite variability in how 'healthy' is defined.
A systematic review and meta-analysis of prospective cohort studies reporting hazard ratios for all-cause mortality in adults with type 2 diabetes, comparing the highest versus lowest tertiles of healthy PDI scores using standardized definitions of whole grains, legumes, nuts, fruits, and vegetables, including at least 8 studies with >3,000 participants each and follow-up >10 years.
A randomized controlled trial would determine whether increasing intake of whole grains, legumes, nuts, fruits, and vegetables in adults with type 2 diabetes directly reduces all-cause mortality over time.
A multicenter, double-blind, parallel-group RCT of 2,500 adults aged 40–75 with type 2 diabetes, randomized to a diet increasing whole plant foods (≥5 servings of vegetables, 3 servings of legumes, 4 servings of nuts/seeds daily) versus a control diet with standard diabetic guidelines, followed for 15 years with all-cause mortality as the primary endpoint and annual metabolic monitoring.
A larger, longer-term prospective cohort study with repeated dietary assessments would confirm whether the association between healthy plant-based diet adherence and mortality persists after accounting for changes in diet over time and residual confounding.
A prospective cohort study of 10,000 adults with type 2 diabetes across multiple countries, with dietary intake assessed annually via 3-day food records and biomarkers (e.g., plasma carotenoids, urinary polyphenols), followed for 20 years, with mortality tracked through national registries and adjustment for socioeconomic status, medication changes, and comorbidities.
A case-control study could compare past dietary patterns in individuals with type 2 diabetes who died during follow-up versus those who survived, to assess whether consumption of healthy plant foods differed before death.
A nested case-control study within the UK Biobank, matching 679 individuals with type 2 diabetes who died during follow-up to 1,358 survivors by age, sex, and diabetes duration, and comparing their dietary intake from the first two 24-hour recalls using the healthy PDI score, with adjustment for baseline covariates.
A cross-sectional study could show whether individuals with type 2 diabetes who consume more healthy plant foods have lower biomarkers of inflammation or metabolic dysfunction at a single point in time, supporting a plausible biological pathway.
A cross-sectional analysis of 5,000 adults with type 2 diabetes measuring healthy PDI scores alongside biomarkers of systemic inflammation (hs-CRP), insulin resistance (HOMA-IR), and lipid profiles to determine if higher intake of whole plant foods correlates with more favorable metabolic profiles.